Question · asked by 1 review

Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone: Dry eye symptoms, measured using the OSDI score (ranging from 0 to 100 units, with a reduction in scores indicating clinical improvement) at 1‐month (with actual

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone
Subjective symptoms of dry eye at 6 months · People with dry eye syndrome
Topical cyclosporine A therapy for dry eye syndrome (2019) · Cochrane Headline outcomes only
no estimate extracted1 study · 56 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Topical cyclosporine A therapy for dry eye syndrome
2019 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.